Hyperfine (HYPR) Research & Development (2021 - 2026)
Hyperfine posted quarterly Research & Development of $3.8 million for Q1 2026, down 23.66% year-on-year from $5.0 million in Q1 2025, and up 0.52% on a QoQ basis from $3.8 million in Q4 2025.
Hyperfine (HYPR) has 6 years of Research & Development data on file, last reported at $3.8 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 23.66% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $16.3 million (down 25.98% YoY), and the FY2025 full-year result was $17.5 million, down 22.44% from the prior year.
- Research & Development for Q1 2026 stood at $3.8 million, up from $3.8 million in the prior quarter.
- Across five years, Research & Development topped out at $8.3 million in Q1 2022 and bottomed at $3.8 million in Q4 2025.
- The 5-year median for Research & Development is $5.5 million (2023), against an average of $5.6 million.
- Peak annual rise in Research & Development reached 86.28% in 2022, while the deepest fall reached 41.31% in 2022.
- A 5-year view of Research & Development shows it stood at $5.2 million in 2022, then rose by 14.24% to $6.0 million in 2023, then slipped by 14.37% to $5.1 million in 2024, then retreated by 25.07% to $3.8 million in 2025, then grew by 0.52% to $3.8 million in 2026.
- The last three Research & Development figures came in at $3.8 million (Q1 2026), $3.8 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | 3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.85 Mn |
| Dec 31, 2025 | 3.83 Mn |
| Sep 30, 2025 | 4.05 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | 5.87 Mn |
| Jun 30, 2024 | 5.96 Mn |
| Mar 31, 2024 | 5.57 Mn |
| Dec 31, 2023 | 5.96 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 5.33 Mn |
| Mar 31, 2023 | 5.46 Mn |
| Dec 31, 2022 | 5.22 Mn |
| Sep 30, 2022 | 7.34 Mn |
| Jun 30, 2022 | 7.27 Mn |
| Mar 31, 2022 | 8.33 Mn |
| Dec 31, 2021 | 8.89 Mn |
| Sep 30, 2021 | 6.44 Mn |
| Jun 30, 2021 | 6.04 Mn |
| Mar 31, 2021 | 4.47 Mn |